Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice

BACKGROUND: Therapeutic idiotypic (Id) vaccination is an experimental treatment for selected B cell malignancies. A broader use of Id-based vaccination, however, is hampered by the complexity and costs due to the individualized production of protein vaccines. These limitations may be overcome by tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruffini, Pier Adelchi, Os, Audun, Dolcetti, Riccardo, Tjønnfjord, Geir E, Munthe, Ludvig A, Bogen, Bjarne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119056/
https://www.ncbi.nlm.nih.gov/pubmed/25059102
http://dx.doi.org/10.1186/1479-5876-12-207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119056/
https://www.ncbi.nlm.nih.gov/pubmed/25059102
http://dx.doi.org/10.1186/1479-5876-12-207

Ejemplares similares